Latest News

SentreHEART Wins EU Clearances for LARIAT LAA Closure System

SentreHEART, based in Silicon Valley, won the European CE mark for its LARIAT-RS 50mm percutaneous left atrial appendage (LAA) closure device. The LARIAT-RS is currently the only product available in Europe that is not an implant, but really a procedure, to fully and permanently close the LAA. In addition to the LARIAT-RS 50 mm being made available, the LARIAT-RS is now also cleared in the EU for left atrial appendage exclusion.

LAAs are common sources of blood clots, as there’s a great deal of turbulence that happens within them. During the LARIAT procedure, physicians use fluoroscopy and echocardiography to push a pre-tied suture to the LAA and position it in place, tying the LAA off and letting it slowly die off. Once the LAA disappears, the chance of a clot arising from the LAA goes away as well.

Here’s a video the demonstrated how the LARIAT procedure works:

Flashback: SentreHEART’s LARIAT Surgical Left Atrial Appendage Suture Delivery Device Coming to Europe…

Product page: LARIAT…

Via: SentreHEART…

Source link

Related posts

10 Italian towns in lockdown over coronavirus fears


Physical activity may reduce mortality risk among cognitively frail individuals


Lower levels of lymphocyte blood cells may indicate increased risk of death


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World